Announcements Trials
Browse Landscape

Phase

Phase NA 9Phase EARLY_PHASE1 5Phase 4 4Phase 2 4Phase 1 2Phase 2/3 1

Status

Unknown 2Completed 2

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gynecologic 2Breast 1

Conditions

Uterine Cervical Dysplasia 1Menorrhagia 1Leiomyoma 1Endometrial Neoplasms 1Endometrial Hyperplasia 1Breast Neoplasms 1

Interventions

Cisplatin 1514Carboplatin 1416Cyclophosphamide 1359Gemcitabine 1235Bevacizumab 1223Paclitaxel 1210Radiotherapy 1173Docetaxel 1079pembrolizumab 1026Oxaliplatin 934Capecitabine 898Fluorouracil 832Rituximab 729Doxorubicin 683Nivolumab 679Dexamethasone 665Etoposide 660Irinotecan 622Leucovorin 574Pemetrexed 508Drug Therapy 491Cetuximab 481Trastuzumab 467Cytarabine 466Magnetic Resonance Spectroscopy 457Filgrastim 446Prednisone 432Lenalidomide 409Specimen Handling 407Temozolomide 400

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Interventional × Progesterone × Clear all
NCT03906669 2023-11-22

WinPro

St Vincent's Hospital

Phase 2 Unknown
200 enrolled
Breast

Breast Neoplasms

NCT01441635 2021-07-13

Safety and Efficacy of Elagolix in Pre-Menopausal Women With Heavy Uterine Bleeding and Uterine Fibroids

AbbVie

Phase 2 Completed
271 enrolled 38 charts

Leiomyoma, Menorrhagia

NCT00247169 2012-03-09

Vaginal Progesterone in the Treatment of Cervical Dysplasia Grade I and II

Medical University of Vienna

Phase 2 Completed
40 enrolled
Gynecologic

Uterine Cervical Dysplasia

NCT00919919 2009-06-12

Efficacy and Tolerability Study of Progesterone Vaginal Tablets (Endometrin®) in Menopausal Women Treated by Estrogen

Rabin Medical Center

Phase 2 Unknown
60 enrolled
Gynecologic

Endometrial Hyperplasia, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡